Ligand id: 9311

Name: urelumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9365 urelumab
BMS 663513 | BMS-663513
Urelumab (BMS-663513) a fully human lgG4 monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9). It is being investigated for potential clinical immunostimulatory activity in the immuno-oncology setting [2-4].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequences for urelumab are identical matches for peptides claimed in patent WO2005035584, which leads to identification of clone 20H4-9-IgG4 [1].
Database Links
Specialist databases
IMGT/mAb-DB 373
Other databases
GtoPdb PubChem SID 318164830
Search PubMed clinical trials urelumab
Search PubMed titles urelumab
Search PubMed titles/abstracts urelumab